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1. Introduction 
To date a number of techniques have been used for cataract surgery. However 
phacoemulsification is the most common method. Other methods such as intra- and 
extracapsular cataract extraction, mini-nuc, phacosection, sandwich and phaconit have also 
been used by many surgeons. Over the years, the techniques of cataract surgery have evolved 
into a safe and successful procedure for visual rehabilitation. The incidence of most 
complications has significantly decreased with better instrumentation and affordable high 
quality intraocular lens implants. Better pre-operative evaluation has helped. This has also 
reduced the number of poor results owing to the presence of other eye diseases in a patient. 
However some risk factors are intrinsic to the patient and, short of avoiding surgery 
altogether, very little can be done to eliminate them. In the event of surgery, high-risk cases 
should be operated on in an appropriate setting, by a surgeon who has the right level of 
experience. Although cataract surgery is safe for the majority of patients, some complications 
that involve the anterior and the posterior segment can occur. Cataract surgery complications 
can be divided into intraoperative complications, and postoperative complications. These 
complications are anaesthesia-related complications, posterior capsular rupture and vitreous 
loss, vitreous prolapse, expulsive haemorrhage, Descemet's membrane detachment, 
intraocular haemorrhage, wound malapposition, shallow anterior chamber, iris prolapse, 
infectious endophthalmitis, corneal oedema, dropped nucleus or retained nuclear fragments, 
suture-induced astigmatism, cystoid macular oedema, retinal detachment, posterior capsule 
opacification, and bullous keratopathy. The most important of these complications are often 
associated with posterior capsular rupture and infectious endophthalmitis. The incidence of 
posterior capsule tear during cataract surgery ranges from 0.2% to 16.0%. A higher incidence 
of posterior capsule tear and vitreous loss is associated with pseudoexfoliation, diabetes 
mellitus, trauma, hard or brunescent nuclei, and white cataract. Postoperative endophthalmitis 
remains a devastating outcome after cataract surgery, despite improved methods of 
prophylaxis, surgical technique, and treatment. This complication causes significant morbidity 
and distress and often severe visual impairment or blindness. The reported incidence of 
endophthalmitis after cataract surgery varies considerably around the world. Occurring about 
once every 500 operations worldwide, the relatively low incidence of endophthalmitis makes it 
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difficult to identify the risk factors clearly. If the posterior capsule tear causes occur vitreous 
loss and dropped fragments or nucleus drop it can lead to long-standing uveitis, vitritis, 
cystoid macular oedema, and secondary glaucoma. In the late period it is important to be 
vigilant in terms of posterior capsular opacification and retinal detachment. In this review, the 
diagnosis, treatment and prevention of early postoperative complications of cataract surgery 
are discussed. Early recognition and prompt treatment of these problems can minimize the 
risk of ocular morbidity. 
2. Endophthalmitis 
Infectious endophthalmitis following cataract surgery is still a devastating condition, 
despite major improvements in surgical techniques in the last decades. Most series report on 
an incidence rate ranging from 0.05% to 0.4% in different studies worldwide (Melo et al., 
2010; Taban et al., 2005). 
Infectious endophthalmitis is defined as infection causing severe inflammation involving 
both the anterior and posterior segments of the eye after intraocular surgery. It is a serious 
intraocular inflammatory condition that also results in infection of the vitreous cavity 
(Lemley & Han, 2007). Although it is rare, it has the potential to have a severe impact on 
vision and may even lead to a loss of the eye. Fortunately a number of factors including 
increased knowledge of the pathogenesis of the condition, improved surgical and diagnostic 
techniques, and a wider choice of management options have led to a decrease in the 
incidence of post-surgical cases. 
Typically, postoperative endophthalmitis is caused by the peri-operative introduction of 
microbial organisms into the eye. The primary source of this intraocular infection is 
considered to be bacteria from the patient’s ocular cornea, conjunctiva, lacrimal glands, 
blepharitis, and extraocular muscles (Maguire, 2008). However, contamination of sterilized 
instruments, disposable supplies, prepared solutions, the surgical field, or the intraocular 
lens, have been reported. Epidemic clusters of endophthalmitis have resulted from these 
types of external contaminations (Cruciani et al., 1998; Gibb et al., 2006). 
The bacteria most frequently isolated are Gram-positive coagulase-negative cocci which 
account for 70% of culture-positive cases. Gram-negative bacteria account for just 6% of 
culture-positive cases; however, an infection with these bacteria, particularly with 
Pseudomonas aeruginosa, can lead to a devastating visual outcome (Eifring et al., 2003; 
Mamalis et al., 2002). 
Once organisms gain access to the vitreous cavity, overwhelming inflammation is likely to 
occur, making rapid recognition, diagnosis and treatment critical in optimizing final 
outcomes. Although most cases of postoperative endophthalmitis occur within 6 weeks of 
surgery, infections seen in high-risk patients or infections caused by slow-growing 
organisms may occur months or years after the procedure (Cruciani et al., 1998; Eifrig et al., 
2002; Taban et al., 2005). 
The most common risk factors are posterior capsular rupture, retained lens material, the 
specific surgical procedure, wound leak and less experienced surgeons. Published studies 
have demonstrated an increased risk of endophthalmitis after placement of a secondary 
intraocular lens, possibly due to prolonged surgical time or ocular manipulation (Eifrig et 
al., 2002). Prolene haptic sutures have also been implicated as a possible risk factor. Other 
factors that are more controversial include increased patient age, corneal incision site and 
wound configuration (Chan et al., 2010).  
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Cataract patients with an acute postoperative form of infectious endophthalmitis may 
present as early as the day after surgery or up to two weeks later. Common clinical ocular 
associations include injection, conjunctival chemosis, purulent discharge, corneal oedema, 
anterior chamber cell and flare reaction, hypopyon, vitreous opacification, choroidal 
swelling, periphlebitis, and retinal haemorrhages. Adnexal swelling may also be present. 
Symptoms classically include pain and decreased vision (Kamalarajah et al., 2004; Kressloff 
et al., 1998; Lemley & Han, 2007; Mamalis et al., 2002). The inflammation seen is significantly 
greater than that otherwise expected post cataract surgery (Kamalarajah et al., 2004). 
Taking appropriate measures to prevent endophthalmitis is crucial. Many different factors 
in cataract surgery have been investigated extensively for their role as a risk factor for 
endophthalmitis. Currently, the three most accepted methods of reducing the risk are to use 
an appropriate antiseptic solution (povidone-iodine), adequate draping of the surgical field 
to exclude the eyelashes and the use of intracameral antibiotics, such as cefuroxime at the 
conclusion of surgery (Chan et al., 2010). 
A definitive approach to treatment of postoperative endophthalmitis is not uniformly 
agreed upon by many vitreoretinal surgeons. Therapeutics generally involves 
administration of intravitreal broad spectrum antibiotics with associated vitreous 
tap/biopsy (VTB) or pars plana vitrectomy (PPV). The choice of topical, peri-ocular, and 
even systemic antibiotics is increasingly controversial compared with 10 years ago (Maguire, 
2008). 
Most cases are caused by Gram-positive and Gram-negative micro-organisms. The 
antibiotics selected should cover the broad range of Gram-positive and Gram-negative 
organisms causing clinical endophthalmitis. Antibiotics can be delivered into the eye by 
several routes, including direct intraocular injection, systemic administration, peri-ocular 
injection, and topical application (Table 1). Out of all the available antimicrobial agents 
evaluated for intraocular injection only a few are used regularly in clinical practice. 
Intraocular vancomycin in combination with an aminoglycoside has been a commonly used 
regimen for the initial empiric treatment of presumed bacterial endophthalmitis (Flynn et 
al., 1991). 
An alternative to the aminoglycosides for coverage of Gram-negative organisms is the use of 
intraocular ceftazidime, a third-generation cephalosporin (Campochiaro & Green, 1992; Jay 
et al., 1987; Stonecipher et al., 1991). These antibiotic combinations will theoretically provide 
broad coverage for nearly all of the organisms causing bacterial endophthalmitis 
(Stonecipher et al., 1991). 
Intravitreal administration is used in order to deliver a high concentration of antibiotic 
directly in the eye. However, repetitive injections of intraocular antibiotics may cause 
significant retinal toxicity. In a rabbit model, eyes treated with a second or third intraocular 
vancomycin/aminoglycoside injection at 48-hour intervals showed progressive toxicity 
(Oum et al., 1989). Topical and subconjunctival antibiotics are often prescribed in addition to 
intravitreal antibiotics in order to increase the concentration of antibiotics within the 
anterior segment of the eye. Aqueous and vitreous solution samples are usually taken and 
sent to the laboratory for cultures. Vitreous samples are more likely to yield positive 
cultures. A smear placed on a glass slide and stained with a variety of chemicals provides a 
rapid result but it is not as sensitive or specific as results obtained from culture growth on 
different types of media. However, the latter can take up to a fortnight and therefore broad 
spectrum treatment must be provided until this is done (Barza et al., 1997).  
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Owing to concern as to whether intraocular antibiotics with or without vitrectomy are 
sufficient to treat infectious endophthalmitis, local ocular therapy is commonly 
supplemented with systemic antibiotics. Intraocular inflammation and/or performing a 
PPV alter the blood-retina barrier in a manner that allows better intravitreal penetration of 
systemically administered antibiotics (Meredith, 1993). 
PPV may be necessary depending on level of vision. As a result of the EVS it is generally felt 
that in patients with light perception only or worse vision, PPV should be performed as the 
results of the study showed that these patients had a significantly better outcome compared 
with other modes of treatment (Endophthalmitis Vitrectomy Study Group [EVSG], 1995). 
The question arises whether PPV should be applied more frequently to patients presenting 
with vision of hand movements (HM) or better (Altan et al., 2009). The advantage of this 
procedure is that it enables the removal of a significant amount of the infecting organism, 
exo- and endotoxins, inflammatory agents, and any opacities and vitreous membranes that 
could result in retinal detachment (EVSG, 1995; Lemley & Han, 2007; Maguire, 2008).  
Detractors of this approach have pointed to potential complications of surgery in severely 
inflamed eyes with poor visibility, a more rapid turnover of intravitreal antibiotics and the 
risks of delayed therapy (Maguire, 2008). Vitreal samples can easily be taken at the same 
time and subsequent intravitreal antibiotic distribution is greatly improved. However, 
significant inflammation may make visualisation difficult when performing the vitrectomy. 
Patients may also require multiple PPV procedures (Lemley & Han, 2007). 
 
Intravenous Abs   
 Ceftazidime 2 g q 8 h (ciprofloxacin 750 p.o. bid)a 
 Amikacin 6.0 mg/kg 12 h 
Intravitreal Abs   
 Vancomycin 1.0 mg 
 Amikacin 0.4 mg 
Subconjunctival Abs   
 Vancomycin 25mg in 0.5 cc 
 Ceftazidime 100mg in 0.5 cc 
 Dexamethasone 6.0mg 
Topical Abs   
 Vancomycin 50 mg/ml gtts q h 
 Amikacin 20 mg/ml gtts q h 
Steroids   
 Prednisone 30mg BID for 5–10 days 
Abbreviations: Abs, antibiotics; bid, twice a day. 
aIn penicillin allergic patients. 
Table 1. Standard pharmacological agents utilized in the Endophthalmitis Vitrectomy Study 
3. Dropped nucleus 
Loss of nuclear material into the vitreous cavity carries a major risk of loss of sight. This 
complicates 0.1% to 1% of cases of cataract extractions (Figure 1.) (Hoeve & Stilma, 2010). It 
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can happen in even experienced hands, and can be a worry as corrective action requires 
intervention in the posterior segment (Lu et al., 1999). Removing a dropped nucleus or even 
nuclear fragments is essential as it can either lead to long-standing uveitis, vitritis, cystoid 
macular oedema, and secondary glaucoma (Kaputsa et al., 1996; Lu et al., 1999). 
 
 
Fig. 1. Dropped nucleus 
Clinical studies implicate posterior extension of breaks in the capsulorrhexis as a common 
cause of this complication. Congenital posterior polar cataract, which predisposes to 
posterior capsular dehiscence, is another risk factor for dropped nucleus (Kim & Miller, 
2002). A higher incidence of posterior capsule tear and vitreous loss is associated with 
pseudoexfoliation, diabetes mellitus, trauma, hard or brunescent nuclei, and white cataract 
(Browning & Cobo, 1985; Guzek et al., 1987). 
Management of these tears is especially difficult when the nucleus begins to drop into the 
vitreous. Rapid intervention is crucial to prevent the nucleus from dropping completely into 
the posterior vitreous. Manoeuvres performed through the anterior segment to retrieve the 
nuclear fragments can worsen the situation. Vitreous will prolapse through the surgical 
incision and, as a consequence, the partially dropped nuclear fragments might sink further 
back. Moreover, these manoeuvres can lead to serious late posterior segment complications 
and the risk for peripheral tears and retinal detachment (Gilliland et al., 1992; Lambrou & 
Stewart, 1992). 
A dropped nucleus can lead to various problems that require additional treatment 
(Horiguchi et al., 2003). The surgeon should be familiar with the option of temporary 
aphakia or a sulcul lens and might also consider views of local surgeons performing PPV. 
Outcomes are typically excellent when there is minimal vitreous manipulation and traction 
and the residual lens material is removed in a controlled fashion by three-port PPV with 
phacofragmentation. It is recommended that PPV be performed within one to two weeks 
after cataract extraction (Hoeve & Stilma, 2010).  
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4. Raised intraocular pressure 
Elevated intraocular pressure is a common problem following cataract surgery. An increase 
in intraocular pressure frequently occurs after otherwise uneventful phacoemulsification 
cataract surgery. The exact mechanism responsible for the acute rise in intraocular pressure 
after phacoemulsification is not known but is probably multifactorial (Unal & Yücel, 2008). 
The first report of ocular hypertension one day after cataract surgery was documented by 
Gormaz in 1962 (Gormaz, 1962).  
In most patients, postoperative increase in intraocular pressure following cataract surgery is 
transient and benign (Tranos et al., 2004). Nearly all patients’ pressures returned to baseline 
with or without treatment. Some individuals, however, may experience pain, corneal 
oedema, glaucomatous nerve damage, or anterior ischemic optic neuropathy (Ermis et al., 
2005).  
Elevated pressure is the most frequent postoperative complication demanding treatment 
following phacoemulsification (Hildebrand et al., 2003). As many as 18% to 45% of patients 
may experience an intraocular pressure greater than 28 mm Hg following 
phacoemulsification, but most pressures will return to normal by 24 hours postoperatively 
(Tranos et al., 2004). The peaks most commonly occur 8 to 12 hours after surgery, and only 
1.3% to 10.0% of cases record an intraocular pressure higher than 30 mm Hg 24 hours 
postoperatively. After uneventful phacoemulsification in eyes without glaucoma, however, 
intraocular pressure spikes may reach 68 mm Hg (Hildebrand et al., 2003). The causes of the 
elevated intraocular pressure are likely multifactorial (Table 2). Causes of elevated 
intraocular pressure are numerous (Bomer et al., 1995; Hildebrand et al., 2003; Tanaka et al., 
1997; Thorofare & Slack, 2007).  
 
Retained lens debris 
Retained viscoelastic 
Hyphaema or red blood cells 
Watertight wound closure 
Use of corneoscleral sutures vs. non-sutured incision 
Steroid response (3 to 6 weeks after surgery) 
Iris pigment release 
Pre-existing glaucoma 
Degree of surgical trauma 
Secluded/occluded pupil with iris bombe 
Uveitis or inflammatory cells 
Expulsive haemorrhage 
Aqueous misdirection 
Epithelial down growth 
Table 2. Causes of increased intraocular pressure following cataract surgery 
It is well accepted that retained viscoelastic material inhibits aqueous outflow through the 
trabecular meshwork resulting in a higher incidence and degree of postoperative increase in 
intraocular pressure (Tanaka et al., 1997). Higher molecular weight viscoelastics have been 
shown to result in a higher rise in post-operative intraocular pressure (Borazan et al., 2007). 
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When considering the various causes of pressure elevation, topical steroids are often 
suspected. However, steroids in the immediate postoperative period are rarely a cause of 
pressure rise. Typically, a steroid-induced glaucoma requires 3 to 6 weeks of continuous use 
to elicit an intraocular pressure response (Thorofare & Slack, 2007). 
The rise in intraocular pressure in the latter group will settle after discontinuation of topical 
steroids but those in the former group will often require anti-glaucoma medication or even 
surgery in more extreme cases (Chan et al., 2010). Surgical trauma, watertight wound 
closure, retained lenticular debris, the release of iris pigment, hyphaema, and inflammation 
are also thought to contribute to elevations in intraocular pressure (Hildebrand et al., 2003).  
Patients at risk for a known increase in intraocular pressure and vision loss should be 
pretreated. There are several classes of drugs used to treat postoperative increases in 
intraocular pressure including: oral and topical carbonic anhydrase inhibitors 
(acetazolamide, brinzolamide, dorzolamide, and methazolamide), prostaglandin analogues 
(latanoprost, bimatoprost, and travoprost), alpha agonists (apraclonidine and brimonidine), 
beta blockers (timolol and levobunolol), and miotics (intracameral carbachol, pilocarpine, 
and intracameral acetylcholine). Although several drugs lower intraocular pressure after 
cataract surgery, none of them consistently prevents pressure increases from occurring 
(Browning et al., 2002; Byrd & Singh, 1998). 
5. Iris prolapse 
Iris prolapse can result from inadequate wound closure, accidental trauma, or raised 
intraocular pressure. Iris prolapse is extremely rare following small incision surgery but 
may occur after extracapsular cataract extraction (Figure 2) (Reddy, 1995). Complications 
include defective wound healing, chronic anterior uveitis, excessive astigmatism, 
endophthalmitis, cystoid macular oedema and epithelial ingrowth (Wright et al., 1988). 
Peribulbar or retrobulbar anaesthesia is necessary for iris manipulation. Treatment depends 
on the time interval between cataract surgery and identification of the prolapse. In cases of 
iris prolapse of less than 48 hours duration, the iris tissue can be reposited. If however, the 
prolapse is of longer duration, the risk of infection mandates that the prolapsed section of 
iris is excised (Byrd & Singh, 1998). 
6. Corneal oedema 
Postoperative corneal oedema can be localized or diffuse. Postoperative localized stromal 
and/or epithelial oedema (Figure 3), especially in the half of the cornea near the main 
section indicates intraoperative trauma. Factors that predispose to corneal oedema following 
cataract surgery include the following: intraoperative mechanical endothelial trauma, prior 
endothelial disease or cell loss, excessive postoperative inflammation, and prolonged 
postoperative elevation of intraocular pressure (Reddy, 1995). 
Raised intraocular pressure manifests as diffuse microcystic epithelial oedema, which is best 
visualized by retro-illumination. Postoperative corneal stromal oedema could also indicate 
pre-existing endothelial pathology as in Fuchs’ endothelial dystrophy. Pre-operatively 
patients should be carefully examined for evidence of Fuchs’ dystrophy or other conditions 
that produce a low endothelial cell count (Reddy, 1995; Wright et al., 1988; Yanoff & Duker, 
2004).  
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Fig. 2. Iris Prolapse (courtesy of Mehmet Baykara, Uludağ University, Bursa) 
 
 
Fig. 3. Corneal Oedema 
Previous studies have found that at birth the corneal endothelial cell density is 
approximately 5,000 cells/mm2 and until the age of 20 years there is a significant decline in 
this number. Subsequently this decrease plateaus to a rate of 0.6% per year. In normal 
circumstances the reserves of endothelial cells mean that there are enough to last a lifetime 
(Edelhauser, 2000). The role of the corneal endothelium is to maintain the correct level of 
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corneal hydration. It forms a physical barrier between the corneal stroma and aqueous 
humour and acts as an ion pump. Injury of a significant number of cells results in significant 
decrease in endothelial cell density and this can impair the ability of the endothelium to 
maintain corneal clarity, resulting in irreversible corneal oedema. The patient will 
experience permanent blurring in their vision and ocular pain. There are a number of factors 
that could lead to endothelial damage during phacoemulsification (Takahashi, 2005).  
Localised temperature increases associated with the phacoemulsification probe can lead to 
thermal damage to adjacent corneal tissue. Some types of phaco probes are now available 
with cooling functions to counteract this effect. High irrigation or aspiration rates can result 
in turbulent flow and air bubbles or lens particles connecting with and causing damage to 
the endothelium. It may be possible to adjust irrigation and aspiration flow rates to 
minimise this. Excessive duration of phacoemulsification may also result in endothelial cell 
damage. The ultrasound energy utilised in phacoemulsification is also associated with the 
production of free radicals (Holst et al., 1993). Free radicals are reactive species with one or 
more unpaired electrons in their outer orbits. Such chemicals can cause damage to the 
corneal endothelium known as oxidative stress (Yanoff & Duker, 2004).  
Pseudophakic bullous keratopathy describes the irreversible oedema and endothelial cell 
damage that occurs after cataract surgery. The advent of phacoemulsification techniques 
and the use of IOLs and ophthalmic viscosurgical devices have helped to reduce the number 
of cases of pseudophakic bullous keratopathy following cataract surgery (Kang et al., 2005). 
The most common cause of corneal endothelial decompensation is surgical trauma 
(Narayanan et al., 2006). 
Postoperatively corneal oedema and inflammation should be aggressively treated with 
topical corticosteroids, and intraocular pressure should be controlled below 20 mmHg. In 
patients with diffuse epithelial oedema, tonometry should be performed and if intraocular 
pressure is raised, the condition should be treated with topical and/or systemic anti-
glaucoma medication. Reduction of intraocular pressure is important for reducing the 
corneal oedema because increased intraocular pressure can compromise endothelial cell 
function, lead to epithelial oedema, and cause further endothelial damage (Narayanan et al., 
2006; Yanoff & Duker, 2004). 
Therapy for pseudophakic corneal oedema and aphakic corneal oedema is aimed at 
reducing discomfort and/or increase visual acuity. The corneal oedema associated with 
phacoemulsification is chronic and usually non-inflammatory. Several medical treatment 
options are available. Epithelial oedema can often be managed with topical hypertonic 
agents such as sodium chloride (5%) ointment or drops. Hypertonic eye ointment at night is 
particularly useful because the oedema tends to be more severe on waking in the morning 
because of lack of evaporation during the night when the eyes are closed (Narayanan et al., 
2006). 
7. Toxic anterior segment syndrome 
Toxic anterior segment syndrome is an acute, sterile, anterior segment inflammation that 
can occur after any anterior segment surgery. Early and intense postoperative inflammation 
after anterior segment surgery accompanied by minimal or no pain, fibrin formation, 
corneal oedema and the absence of vitreous involvement are the diagnostic criteria for toxic 
anterior segment syndrome. It almost always occurs as a complication of uneventful cataract 
surgery or anterior segment surgery and can result in damage to the intraocular tissues 
(Huang et al., 2010). 
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Toxic anterior segment syndrome most commonly occurs acutely following anterior 
segment surgery, typically 12-72 h after cataract extraction. Anterior segment inflammation 
is usually quite severe with hypopyon. Endothelial cell damage is common, resulting in 
diffuse corneal oedema. Most patients are asymptomatic with the exception of blurred 
vision; others may complain of mild discomfort. No bacterium is isolated from ocular 
samples. The causes of toxic anterior segment syndrome are numerous and difficult to 
isolate (Cornut & Chiquet, 2011). 
The primary differential diagnosis is infectious endophthalmitis (Table 3). Development of 
new techniques such as polymerase chain reaction may prove more useful in the 
differentiation of sterile endophthalmitis and early infectious endophthalmitis (Holland et 
al., 2007; Van Gelder, 2001). Fibrinous uveitis of its own does not usually cause corneal 
clouding but can also enter the differential diagnosis. 
 
Characteristics 
Infectious 
endophthalmitis 
Toxic anterior 
segment syndrome 
Onset 3–7 days 1–3 days 
Symptoms Pain, blurred vision Blurred vision 
Cornea Oedema 2 + Oedema 1 + 
Anterior chamber 
Cells 3 +, Fibrin variable, 
Hypopyon 3 + 
Cells 1–3 +, Fibrin 1–3 +, 
Hypopyon 1 + 
Vitreous Vitritis Clear 
Response to steroids Negative Positive 
Table 3. Diagnosis: infectious endophthalmitis versus toxic anterior segment syndrome 
Anterior segment findings include fibrin formation with occasional hypopyon and, in later 
stages, inflammatory membranes that can cause pupil distortion and glaucoma. Severe 
disease can lead to permanent endothelial damage, profound cystoid macular oedema, a 
permanently dilated pupil, and even permanent damage to the trabecular meshwork 
leading to resistant glaucoma that requires multiple operations (Holland et al., 2007; Parikh 
& Edelhauser, 2003). 
Toxic anterior segment syndrome has numerous causes, and most cases are attributed to 1) 
contaminants on surgical instruments, resulting from improper or insufficient cleaning; 2) 
products introduced into the eye during surgery, such as irrigating solutions or ophthalmic 
medications; or 3) other substances that enter the eye during or after surgery, such as topical 
ointments or talc from surgical gloves (Mamalis et al., 2006).  
Gram-negative bacteria may proliferate if the water reservoir in the phaco machine or inside 
the autoclave is not replaced on a regular basis. Gram-negative bacteria are typically 
destroyed during the autoclaving procedure; however, heat-stable lipopolysaccharide 
endotoxin may remain behind. Endotoxin deposits are removed only by acetone or alcohol 
if operating instruments are dry. If heat-stable lipopolysaccharide endotoxin gets into the 
eye during the operation, it may cause severe anterior segment inflammation. Prevention of 
Toxic anterior segment syndrome primarily depends on using appropriate protocols for 
cleaning and sterilizing surgical equipment and paying careful attention to all solutions, 
medications and ophthalmic devices used during anterior segment surgery (Avisar & 
Weinberger, 2010; Mamalis et al., 2006).  
 
Early Post-Operative Complications in Cataract Surgery 255 
Management of toxic anterior segment syndrome involves use of topical steroids every hour 
and non-steroidal anti-inflammatory drugs (NSAIDs) every 6 hours. Milder cases will 
resolve from within a few days to 1 to 3 weeks, but if persisting for more than 6 weeks more 
dire consequences are likely (Parikh & Edelhauser, 2003). 
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